DIRE vs Advantmed OnPoint NP
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
DIRE
This tool assists clinicians in evaluating the risk and potential success of prescribing opioids for chronic pain. It uses a scoring system based on seven factors to guide decision-making, but does not replace professional judgment.
- Opioid prescribing risk assessment
- Seven-factor scoring system
- Chronic non-malignant pain focus
- Decision-making aid for clinicians
- Risk vs. success prediction
Read full descriptionHide full description
The DIRE Score is a tool that can be used to aid clinicians in their decision-making process when considering prescribing opioids for chronic non-malignant pain. Using the DIRE Score, the clinician rates seven factors each on a scale of 1, 2 or 3 with 1 being the least favorable or highest risk for prescribing opioids and 3 being the most compelling or lowest risk for prescribing. The seven DIRE factors are: Diagnosis, Intractability, Risk (there are four risk factors—psychological and chemical health, patient reliability and social support/life roles) and Efficacy. Adding the scores for these seven factors gives a total of 7 – 21. A score of 7-13 was predictive of a low probability of success when prescribing opioids; whereas a score of 14-21 was more likely to be associated with a successful prescribing process and outcome. The DIRE Score does not take into account medical risk factors for opioid prescribing such as comorbid medical conditions (chronic obstructive lung disease, sleep apnea, concomitant use of benzodiazepines, etc.). The clinician should understand that active use of illicit drugs, drug diversion and other aberrant behaviors is incompatible with ongoing opioid prescribing no matter what the DIRE Score may be. The DIRE Score is not meant to be a substitute for sound clinical judgment in the context of any individual patient. This App is meant for informational use only, and is not intended to aid in the diagnosis, treatment or prevention of disease. Decisions about prescribing are solely the responsibility of the licensed prescriber.
Advantmed OnPoint NP
This app allows Nurse Practitioners to manage their appointment schedules and submit visit statuses. NPs can share their availability and receive daily appointment schedules to collect patient health status. The application tracks visit completion and allows for daily status comments.
- Schedule appointments
- Share NP availability
- Receive appointment schedules
- Submit visit completion status
- Track pending visits
- Submit daily status comments
Read full descriptionHide full description
The purpose of this application to schedule appointment for the Nurse Practitioners (NP). The NP visits members (patients) as per appointments in order to collect their health status. In this application, NP can share his/her availability against the upcoming calendar days. NP will receive appointment schedule for upcoming days. Once visit is done, NP will submit the status of the an appointment on same day as completed. If NP misses to submit the status of visit, Application will show visit status as pending. Also, NP can share daily status comments which will be submitted to the server.
Screenshots
Verdict
The clearest difference is review sentiment: DIRE at 100% against Advantmed OnPoint NP's 0%. DIRE also leads on rating (5.0 vs 4.2) and iOS requirement (12.0 vs 15.6). Advantmed OnPoint NP's advantage is update cadence (monthly vs every 51 months) and ratings volume (5 vs 1). On price, ads, in-app purchases and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
DIRE holds the better App Store score, 5.0 against 4.2. That said, the two scores are not equally well evidenced: Advantmed OnPoint NP has 5 ratings behind it against 1, so its average is the more settled of the two. Written reviews point the same way: 100% of DIRE's written reviews are positive against 0% of Advantmed OnPoint NP's.
DIRE ships an update every 51 months, Advantmed OnPoint NP monthly. The most recent releases landed on November 2, 2026 and November 3, 2026 respectively.
| Parameter | DIRE | Advantmed OnPoint NP |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (1 ratings) — better | 4.2 (5 ratings) |
| Positive reviews | 100.0% of reviews — better | 0.0% of reviews |
| Number of ratings | 1 | 5 — better |
| Update frequency | Every 51 months | Monthly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 12.0 — better | 15.6 |
| Further details — not scored | ||
| Size | 8 MB | 34 MB |
| Age rating | 17+ | 4+ |
| Developer | Riemenrade Studios LLC | ADVANTMED INDIA LLP |
Customer experience
DIRE
Advantmed OnPoint NP
In-app purchases
DIRE
No in-app purchases
Advantmed OnPoint NP
No in-app purchases
Questions
Is DIRE free?
Is Advantmed OnPoint NP free?
Which has better reviews, DIRE or Advantmed OnPoint NP?
Do DIRE or Advantmed OnPoint NP have ads?
Which is updated more often, DIRE or Advantmed OnPoint NP?
Other comparisons















